Breast Cancer Research

official impact factor 5.79

Email this article to a friend

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?

Bryan P Schneider and George W Sledge*

Breast Cancer Research 2009, 11:303 doi:10.1186/bcr2250

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.